EX-FILING FEES 5 tm2323585d6_ex-filingfees.htm EX-FILING FEES

Exhibit 107.1

 

Calculation of Filing Fee Tables

 

Form S-3
(Form Type)

 

Ampio Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

  Security Type Security Class Title Fee Calculation or Carry
Forward Rule
Amount
Registered

Proposed
Maximum
Offering Price
Per
Unit

Maximum
Aggregate
Offering Price
Fee Rate Amount of
Registration Fee
Newly Registered Securities
Fees to Be Paid Equity Common Stock,
$0.0001 par value
per share
457(o) (1) (1) (1)    
Equity Preferred Stock,
$0.0001 par value
per share
457(o) (1) (1) (1)    
  Other Warrants 457(o) (1) (1) (1)    
  Other Units 457(o) (1) (1) (1)    
  Unallocated
(Universal)
Shelf
  457(o) (1) (1) $50,000,000 .00011020 $5,510(2)
  Total Offering Amounts   $50,000,000   $5,510.00
  Total Fees Previously Paid       $0.00
  Total Fee Offsets       $0.00 
  Net Fee Due       $5,510.00  

 

(1)Omitted pursuant to General Instruction II.D of Form S-3 under the Securities Act of 1933, as amended (the "Securities Act"). There is being registered hereunder an indeterminate number or amount, as the case may be, of the securities of each identified class as may from time to time be offered and sold at indeterminate prices, which together shall have a maximum aggregate offering price not to exceed $50,000,000. Any securities registered hereunder may be sold separately or in combination with the other securities registered hereunder. The securities registered hereunder also include an indeterminate number or amount, as the case may be, of securities registered hereunder as may be issued upon conversion, redemption, exchange, exercise or settlement, as applicable of any other securities registered hereunder that provide for such conversion, redemption, exchange, exercise or settlement, including such securities as may be issued pursuant to anti-dilution adjustments pursuant to the anti-dilution provisions of any such securities or as a result of stock splits, stock dividends or similar transactions, pursuant to Rule 416 under the Securities Act.
(2)Calculated in accordance with Rule 457(o) under the Securities Act.